<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">MOUFFOUK Chaima</style></author><author><style face="normal" font="default" size="100%">MOUFFOUK soumia</style></author><author><style face="normal" font="default" size="100%">Mouffouk Sara</style></author><author><style face="normal" font="default" size="100%">Hambaba Leila</style></author><author><style face="normal" font="default" size="100%">Haba Hamada</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CL&lt;sup&gt;pro&lt;/sup&gt; and PL&lt;sup&gt;pro&lt;/sup&gt;), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2)</style></title><secondary-title><style face="normal" font="default" size="100%">European Journal of Pharmacology</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2020</style></year></dates><volume><style face="normal" font="default" size="100%">891</style></volume><pages><style face="normal" font="default" size="100%">173759</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><issue><style face="normal" font="default" size="100%">2021</style></issue></record></records></xml>